Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Hepatology. 2022 Jul 7;77(4):1164–1180. doi: 10.1002/hep.32608

Figure 8. Fecal levels of miR194, bile acids and taurine in AH patients.

Figure 8.

Stool samples were lyophilized before analyses. (A) Fecal bile acids and miR194 levels. (C) Fecal taurine concentrations and correlations between fecal taurine concentrations and serum AST levels. (D) Fecal BSH activity and correlation between BSH activity and serum AST levels. (E) A proposed model of LDNPs prevention against ALD through modulation of intestinal miR194-FXR-FGF15 signaling.